Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $260000.0.

  • Enanta Pharmaceuticals' Other Non-Current Liabilities rose 1255.41% to $260000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $260000.0, marking a year-over-year increase of 1255.41%. This contributed to the annual value of $260000.0 for FY2025, which is 1255.41% up from last year.
  • As of Q3 2025, Enanta Pharmaceuticals' Other Non-Current Liabilities stood at $260000.0, which was up 1255.41% from $252000.0 recorded in Q2 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Other Non-Current Liabilities registered a high of $994000.0 during Q1 2021, and its lowest value of $224000.0 during Q1 2024.
  • For the 5-year period, Enanta Pharmaceuticals' Other Non-Current Liabilities averaged around $487210.5, with its median value being $426000.0 (2023).
  • In the last 5 years, Enanta Pharmaceuticals' Other Non-Current Liabilities surged by 5676.33% in 2023 and then crashed by 6515.84% in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Other Non-Current Liabilities (Quarter) stood at $856000.0 in 2021, then plummeted by 51.64% to $414000.0 in 2022, then surged by 56.76% to $649000.0 in 2023, then crashed by 63.79% to $235000.0 in 2024, then rose by 10.64% to $260000.0 in 2025.
  • Its Other Non-Current Liabilities was $260000.0 in Q3 2025, compared to $252000.0 in Q2 2025 and $243000.0 in Q1 2025.